Global Anti-Migraine Drugs Sales Market Report 2017
  • Published Date: 25-Aug-17 | Pages: 118
  • Single User: 4000 USD | Multi User: 8000 USD

  • Description

                          In this report, the global Anti-Migraine Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
    
    Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Anti-Migraine Drugs for these regions, from 2012 to 2022 (forecast), covering
        United States
        China
        Europe
        Japan
        Southeast Asia
        India
    
    Global Anti-Migraine Drugs market competition by top manufacturers/players, with Anti-Migraine Drugs sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
        Eli Lilly
        Abbott Laboratories
        Eisai
        Allergan
        Endo
        GlaxoSmithKline
        Impax Laboratories
        Pfizer
        AstraZeneca
        Bayer
        Johnson & Johnson
        Merck
        Teva
        Allergan
        Amgen
    On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
        Triptans
        Ergots
        Others
    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Anti-Migraine Drugs for each application, including
        Women
        Men
    
    If you have any special requirements, please let us know and we will offer you the report as you want.
    
                        

    Research Methodology

                   QY Reports in their recently published report, have emphasized upon the unique and key findings of the industry for a particular assessment period. The report mainly categorizes the custom market survey conducted by the experts to collect high-quality data analysis and visualization to bring out the various dynamics of the industry. It offers a detailed information about the latest updates such as several new technological advancements made, mergers and acquisitions, new entrants in the market, which make an impact on different segments of the industry.
    
    Segmental Analysis
    The global industry has been segmented on the basis of its products, regions, end users, technology, applications and cues for positioning, advertising & communication strategies. For a better understanding of the market, QY Reports has also provided a detailed analysis of drivers, restraints, and opportunities that dominate the present market scenario and also provides the anticipation of the future status of this industry.
    QY Reports emphasizes on the essentials of analyzing qualitative and quantitative aspects of the industry. While giving a brief idea about the revenue opportunities for all the segments, this report has also provided the impact of industry expertise to determine the scope of the study for all the segments over the predicted period.
    
    Regional Analysis
    The report comprises of the geographical landscape of the industry and is briefly segmented into key regions such as North America, the Asia Pacific, Latin America, and the Middle East and Africa. Our research methodology also focuses on understanding the niche countries such as Vietnam, Indonesia, Thailand, Malaysia, Mexico, and Italy to give lucid essence of the country-wide acceptance and growth of this industry. It also provides the reader with extensive data related to the market thus, empowering them to make informed decisions about doing business.
    
    Our infallible research methodology offers flexibility to suit varying budgets, deadlines, and altering market dynamics. Our researches cover a detailed comprehension of a wide spectrum of products and services, along with the business strategies adopted by the new entrants who are trying to establish themselves in the competitive landscape. The market size and revenue generated by each segments has been analyzed with the help of Basis Point Share technique, which accurately calculates the percentage change in the value of trending products.
    
    QY Reports is committed to offer a targeted market view in order to eliminate redundant information for the complete satisfaction of thereader.
    
    Various sales channels such as Original Equipment Manufacturers and aftermarkets across various key regions are covered in this report.
    
    Our quantitative research approach identifies the market size and how much it might be worth to find areas for sales growth. It also helps the reader understand the demographics of customers, such as their gender and age. The qualitative research renders a better understanding of the customer requirements and identifies opportunities for enhancing sales and also improving customer service.
    
    Our research experts have focused on to offer a detailed description of the supply side of the business before placing the product in the market. The syndicated research covers critical aspects of market research to generate useful strategies that ensure accurate analysis, high-level data integrity, and impeccable forecasts. On-demand customization or bespoke proposals are rendered to exactly meet the customer needs. The information provided regarding the geographical segmentation and the competitive landscape is based on the study done on the authenticated data from direct observations, online surveys, government agencies, industry bodies, and expert interviews.
    
    QY Reports offers market attractiveness, which presents a market index to help the clients and target audiences recognize the numerous opportunities that the industry holds.
    
    In order to authenticate the data, our experts have interviewed the industry experts on various panels across the globe who have sufficient experience and knowledge related to the field. QY Reports has used frameworks such as Year on Year growth forecast, parent market overview for data analysis, and the performance of various macroeconomic factors. Also, the analysts have gathered all the necessary information from the annual reports of various companies, their official websites, and some paid publications in order to offer full-proof reports to our clients.
    
    The report has developed a time-bound strategic roadmap for the readers by weaving different aspects of business into a winning fabric.
                 

                          Table of Contents
    
    Global Anti-Migraine Drugs Sales Market Report 2017
    1 Anti-Migraine Drugs Market Overview
        1.1 Product Overview and Scope of Anti-Migraine Drugs
        1.2 Classification of Anti-Migraine Drugs by Product Category
            1.2.1 Global Anti-Migraine Drugs Market Size (Sales) Comparison by Type (2012-2022)
            1.2.2 Global Anti-Migraine Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
            1.2.3 Triptans
            1.2.4 Ergots
            1.2.5 Others
        1.3 Global Anti-Migraine Drugs Market by Application/End Users
            1.3.1 Global Anti-Migraine Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022)
            1.3.2 Women
            1.3.3 Men
        1.4 Global Anti-Migraine Drugs Market by Region
            1.4.1 Global Anti-Migraine Drugs Market Size (Value) Comparison by Region (2012-2022)
            1.4.2 United States Anti-Migraine Drugs Status and Prospect (2012-2022)
            1.4.3 China Anti-Migraine Drugs Status and Prospect (2012-2022)
            1.4.4 Europe Anti-Migraine Drugs Status and Prospect (2012-2022)
            1.4.5 Japan Anti-Migraine Drugs Status and Prospect (2012-2022)
            1.4.6 Southeast Asia Anti-Migraine Drugs Status and Prospect (2012-2022)
            1.4.7 India Anti-Migraine Drugs Status and Prospect (2012-2022)
        1.5 Global Market Size (Value and Volume) of Anti-Migraine Drugs (2012-2022)
            1.5.1 Global Anti-Migraine Drugs Sales and Growth Rate (2012-2022)
            1.5.2 Global Anti-Migraine Drugs Revenue and Growth Rate (2012-2022)
    
    2 Global Anti-Migraine Drugs Competition by Players/Suppliers, Type and Application
         2.1 Global Anti-Migraine Drugs Market Competition by Players/Suppliers
            2.1.1 Global Anti-Migraine Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
            2.1.2 Global Anti-Migraine Drugs Revenue and Share by Players/Suppliers (2012-2017)
        2.2 Global Anti-Migraine Drugs (Volume and Value) by Type
            2.2.1 Global Anti-Migraine Drugs Sales and Market Share by Type (2012-2017)
            2.2.2 Global Anti-Migraine Drugs Revenue and Market Share by Type (2012-2017)
        2.3 Global Anti-Migraine Drugs (Volume and Value) by Region
            2.3.1 Global Anti-Migraine Drugs Sales and Market Share by Region (2012-2017)
            2.3.2 Global Anti-Migraine Drugs Revenue and Market Share by Region (2012-2017)
        2.4 Global Anti-Migraine Drugs (Volume) by Application
    
    3 United States Anti-Migraine Drugs (Volume, Value and Sales Price)
        3.1 United States Anti-Migraine Drugs Sales and Value (2012-2017)
            3.1.1 United States Anti-Migraine Drugs Sales and Growth Rate (2012-2017)
            3.1.2 United States Anti-Migraine Drugs Revenue and Growth Rate (2012-2017)
            3.1.3 United States Anti-Migraine Drugs Sales Price Trend (2012-2017)
        3.2 United States Anti-Migraine Drugs Sales Volume and Market Share by Players
        3.3 United States Anti-Migraine Drugs Sales Volume and Market Share by Type
        3.4 United States Anti-Migraine Drugs Sales Volume and Market Share by Application
    
    4 China Anti-Migraine Drugs (Volume, Value and Sales Price)
        4.1 China Anti-Migraine Drugs Sales and Value (2012-2017)
            4.1.1 China Anti-Migraine Drugs Sales and Growth Rate (2012-2017)
            4.1.2 China Anti-Migraine Drugs Revenue and Growth Rate (2012-2017)
            4.1.3 China Anti-Migraine Drugs Sales Price Trend (2012-2017)
        4.2 China Anti-Migraine Drugs Sales Volume and Market Share by Players
        4.3 China Anti-Migraine Drugs Sales Volume and Market Share by Type
        4.4 China Anti-Migraine Drugs Sales Volume and Market Share by Application
    
    5 Europe Anti-Migraine Drugs (Volume, Value and Sales Price)
        5.1 Europe Anti-Migraine Drugs Sales and Value (2012-2017)
            5.1.1 Europe Anti-Migraine Drugs Sales and Growth Rate (2012-2017)
            5.1.2 Europe Anti-Migraine Drugs Revenue and Growth Rate (2012-2017)
            5.1.3 Europe Anti-Migraine Drugs Sales Price Trend (2012-2017)
        5.2 Europe Anti-Migraine Drugs Sales Volume and Market Share by Players
        5.3 Europe Anti-Migraine Drugs Sales Volume and Market Share by Type
        5.4 Europe Anti-Migraine Drugs Sales Volume and Market Share by Application
    
    6 Japan Anti-Migraine Drugs (Volume, Value and Sales Price)
        6.1 Japan Anti-Migraine Drugs Sales and Value (2012-2017)
            6.1.1 Japan Anti-Migraine Drugs Sales and Growth Rate (2012-2017)
            6.1.2 Japan Anti-Migraine Drugs Revenue and Growth Rate (2012-2017)
            6.1.3 Japan Anti-Migraine Drugs Sales Price Trend (2012-2017)
        6.2 Japan Anti-Migraine Drugs Sales Volume and Market Share by Players
        6.3 Japan Anti-Migraine Drugs Sales Volume and Market Share by Type
        6.4 Japan Anti-Migraine Drugs Sales Volume and Market Share by Application
    
    7 Southeast Asia Anti-Migraine Drugs (Volume, Value and Sales Price)
        7.1 Southeast Asia Anti-Migraine Drugs Sales and Value (2012-2017)
            7.1.1 Southeast Asia Anti-Migraine Drugs Sales and Growth Rate (2012-2017)
            7.1.2 Southeast Asia Anti-Migraine Drugs Revenue and Growth Rate (2012-2017)
            7.1.3 Southeast Asia Anti-Migraine Drugs Sales Price Trend (2012-2017)
        7.2 Southeast Asia Anti-Migraine Drugs Sales Volume and Market Share by Players
        7.3 Southeast Asia Anti-Migraine Drugs Sales Volume and Market Share by Type
        7.4 Southeast Asia Anti-Migraine Drugs Sales Volume and Market Share by Application
    
    8 India Anti-Migraine Drugs (Volume, Value and Sales Price)
        8.1 India Anti-Migraine Drugs Sales and Value (2012-2017)
            8.1.1 India Anti-Migraine Drugs Sales and Growth Rate (2012-2017)
            8.1.2 India Anti-Migraine Drugs Revenue and Growth Rate (2012-2017)
            8.1.3 India Anti-Migraine Drugs Sales Price Trend (2012-2017)
        8.2 India Anti-Migraine Drugs Sales Volume and Market Share by Players
        8.3 India Anti-Migraine Drugs Sales Volume and Market Share by Type
        8.4 India Anti-Migraine Drugs Sales Volume and Market Share by Application
    
    9 Global Anti-Migraine Drugs Players/Suppliers Profiles and Sales Data
        9.1 Eli Lilly
            9.1.1 Company Basic Information, Manufacturing Base and Competitors
            9.1.2 Anti-Migraine Drugs Product Category, Application and Specification
                9.1.2.1 Product A
                9.1.2.2 Product B
            9.1.3 Eli Lilly Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
            9.1.4 Main Business/Business Overview
        9.2 Abbott Laboratories
            9.2.1 Company Basic Information, Manufacturing Base and Competitors
            9.2.2 Anti-Migraine Drugs Product Category, Application and Specification
                9.2.2.1 Product A
                9.2.2.2 Product B
            9.2.3 Abbott Laboratories Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
            9.2.4 Main Business/Business Overview
        9.3 Eisai
            9.3.1 Company Basic Information, Manufacturing Base and Competitors
            9.3.2 Anti-Migraine Drugs Product Category, Application and Specification
                9.3.2.1 Product A
                9.3.2.2 Product B
            9.3.3 Eisai Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
            9.3.4 Main Business/Business Overview
        9.4 Allergan
            9.4.1 Company Basic Information, Manufacturing Base and Competitors
            9.4.2 Anti-Migraine Drugs Product Category, Application and Specification
                9.4.2.1 Product A
                9.4.2.2 Product B
            9.4.3 Allergan Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
            9.4.4 Main Business/Business Overview
        9.5 Endo
            9.5.1 Company Basic Information, Manufacturing Base and Competitors
            9.5.2 Anti-Migraine Drugs Product Category, Application and Specification
                9.5.2.1 Product A
                9.5.2.2 Product B
            9.5.3 Endo Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
            9.5.4 Main Business/Business Overview
        9.6 GlaxoSmithKline
            9.6.1 Company Basic Information, Manufacturing Base and Competitors
            9.6.2 Anti-Migraine Drugs Product Category, Application and Specification
                9.6.2.1 Product A
                9.6.2.2 Product B
            9.6.3 GlaxoSmithKline Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
            9.6.4 Main Business/Business Overview
        9.7 Impax Laboratories
            9.7.1 Company Basic Information, Manufacturing Base and Competitors
            9.7.2 Anti-Migraine Drugs Product Category, Application and Specification
                9.7.2.1 Product A
                9.7.2.2 Product B
            9.7.3 Impax Laboratories Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
            9.7.4 Main Business/Business Overview
        9.8 Pfizer
            9.8.1 Company Basic Information, Manufacturing Base and Competitors
            9.8.2 Anti-Migraine Drugs Product Category, Application and Specification
                9.8.2.1 Product A
                9.8.2.2 Product B
            9.8.3 Pfizer Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
            9.8.4 Main Business/Business Overview
        9.9 AstraZeneca
            9.9.1 Company Basic Information, Manufacturing Base and Competitors
            9.9.2 Anti-Migraine Drugs Product Category, Application and Specification
                9.9.2.1 Product A
                9.9.2.2 Product B
            9.9.3 AstraZeneca Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
            9.9.4 Main Business/Business Overview
        9.10 Bayer
            9.10.1 Company Basic Information, Manufacturing Base and Competitors
            9.10.2 Anti-Migraine Drugs Product Category, Application and Specification
                9.10.2.1 Product A
                9.10.2.2 Product B
            9.10.3 Bayer Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
            9.10.4 Main Business/Business Overview
        9.11 Johnson & Johnson
        9.12 Merck
        9.13 Teva
        9.14 Allergan
        9.15 Amgen
    
    10 Anti-Migraine Drugs Maufacturing Cost Analysis
        10.1 Anti-Migraine Drugs Key Raw Materials Analysis
            10.1.1 Key Raw Materials
            10.1.2 Price Trend of Key Raw Materials
            10.1.3 Key Suppliers of Raw Materials
            10.1.4 Market Concentration Rate of Raw Materials
        10.2 Proportion of Manufacturing Cost Structure
            10.2.1 Raw Materials
            10.2.2 Labor Cost
            10.2.3 Manufacturing Process Analysis of Anti-Migraine Drugs
        10.3 Manufacturing Process Analysis of Anti-Migraine Drugs
    
    11 Industrial Chain, Sourcing Strategy and Downstream Buyers
        11.1 Anti-Migraine Drugs Industrial Chain Analysis
        11.2 Upstream Raw Materials Sourcing
        11.3 Raw Materials Sources of Anti-Migraine Drugs Major Manufacturers in 2016
        11.4 Downstream Buyers
    
    12 Marketing Strategy Analysis, Distributors/Traders
        12.1 Marketing Channel
            12.1.1 Direct Marketing
            12.1.2 Indirect Marketing
            12.1.3 Marketing Channel Development Trend
        12.2 Market Positioning
            12.2.1 Pricing Strategy
            12.2.2 Brand Strategy
            12.2.3 Target Client
        12.3 Distributors/Traders List
    
    13 Market Effect Factors Analysis
        13.1 Technology Progress/Risk
            13.1.1 Substitutes Threat
            13.1.2 Technology Progress in Related Industry
        13.2 Consumer Needs/Customer Preference Change
        13.3 Economic/Political Environmental Change
    
    14 Global Anti-Migraine Drugs Market Forecast (2017-2022)
        14.1 Global Anti-Migraine Drugs Sales Volume, Revenue and Price Forecast (2017-2022)
           14.1.1 Global Anti-Migraine Drugs Sales Volume and Growth Rate Forecast (2017-2022)
           14.1.2 Global Anti-Migraine Drugs Revenue and Growth Rate Forecast (2017-2022)
           14.1.3 Global Anti-Migraine Drugs Price and Trend Forecast (2017-2022)
        14.2 Global Anti-Migraine Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
           14.2.1 Global Anti-Migraine Drugs Sales Volume and Growth Rate Forecast by Regions (2017-2022)
           14.2.2 Global Anti-Migraine Drugs Revenue and Growth Rate Forecast by Regions (2017-2022)
           14.2.3 United States Anti-Migraine Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
           14.2.4 China Anti-Migraine Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
           14.2.5 Europe Anti-Migraine Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
           14.2.6 Japan Anti-Migraine Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
           14.2.7 Southeast Asia Anti-Migraine Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
           14.2.8 India Anti-Migraine Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
        14.3 Global Anti-Migraine Drugs Sales Volume, Revenue and Price Forecast by Type (2017-2022)
           14.3.1 Global Anti-Migraine Drugs Sales Forecast by Type (2017-2022)
           14.3.2 Global Anti-Migraine Drugs Revenue Forecast by Type (2017-2022)
           14.3.3 Global Anti-Migraine Drugs Price Forecast by Type (2017-2022)
        14.4 Global Anti-Migraine Drugs Sales Volume Forecast by Application (2017-2022)
    
    15 Research Findings and Conclusion
    
    16 Appendix
        16.1 Methodology/Research Approach
            16.1.1 Research Programs/Design
            16.1.2 Market Size Estimation
            16.1.3 Market Breakdown and Data Triangulation
        16.2 Data Source
            16.2.1 Secondary Sources
            16.2.2 Primary Sources
        16.3 Disclaimer